CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Open-market buy Chief Innovation/Tech Officer bought 1,000 shares at $7.78 ($7,780)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Innovation/Tech Officer bought 2,000 shares at $8.69 ($17,380)
- 4 Open-market buy SVP-Chief Strategy/Dev Officer bought 1,000 shares at $8.00 ($8,000)
- 4 Open-market buy SVP-Chief Financial Officer bought 5,000 shares at $8.87 ($44,350)
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 7,177 shares (to pay taxes)
- 4 Open-market buy Commercial Leader bought 1,445 shares at $10.15 ($14,667)
- 4 Open-market buy General Counsel bought 1,000 shares at $10.57 ($10,570)
- 4 Open-market buy CEO and President bought 1,000 shares at $9.87 ($9,870)
- 4 Open-market buy SVP-HR and Org. Development bought 500 shares at $10.34 ($5,170)
- 4 Open-market buy Chief Innovation/Tech Officer bought 1,000 shares at $10.25 ($10,250)
- 4 Open-market buy SVP-Chief Financial Officer bought 10,000 shares at $9.80 ($98,000)
- 4 Open-market buy CEO and President bought 7,950 shares at an average $10.10 ($80,325)
- 4 Open-market buy SVP-Operations/Value Delivery bought 200 shares at $9.98 ($1,996)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 8-K Event Other events
- 4 Shares withheld for taxes CEO and President gave up 162 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 162 shares (to pay taxes)
Page 31 of 35 · 689 filings